A Study to Evaluate the Effect of CCX140-B on Urinary Albumin Excretion in Subjects With Type 2 Diabetes and Albuminuria

Clinical trial NCT01440257 · COMPLETED

Trial details

NCT number: NCT01440257
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Nephropathy Type 2 Diabetes Mellitus

Start date: 2011-09-01
Primary completion: 2013-02-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.